SBC
SBC Medical Group Holdings Incorporated · NASDAQ · Industrials · USD · 10-K for 2025, filed 2026-03-27
Figures on this page computed 2026-11-08 12:40 UTC
Last close
5.32USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-27
10.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-27
30.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
29.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
13.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
0.21Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth9.4%53 of 100, above its sector
- Returns on capital30.8%91 of 100, above its sector
- Margins73.3%88 of 100, above its sector
- Price10.1x63 of 100, above its sector
- Safety0.2181 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Measure by measure
behind on 0 of 2- Profit on each unit of sales29.4%7.3%Ahead
Higher is better here.
- Return on the capital it uses30.8%n/an/a
Higher is better here.
- Sales growth over five yearsn/a8.1%n/a
Higher is better here.
- Debt against equity0.21n/an/a
Lower is better here.
- Gross margin73.3%n/an/a
Higher is better here.
- Price against earnings10.1x24.0xAhead
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against CRA International, Inc., SBC is behind on 0 of 2 measures.
Against CRA International, Inc., SBC is behind on 0 of 2 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-03-27
Profit on each unit of sales29.4%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
Return on the capital it uses30.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
Sales growth over five yearsn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
Debt against equity0.21
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
Gross margin73.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD
Price against earnings10.1x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-127557
- Reported in
- USD